Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
Sign Up to like & getrecommendations! Published in 2018 at "Drug discovery today"
DOI: 10.1016/j.drudis.2018.05.033
Abstract: The new generation of nanoparticles (NPs) encompass attributes of lipids and polymers and are referred to as 'lipid-polymer hybrid nanoparticles' (LPHNPs). LPHNPs have helped shed light on the mechanisms involved in targeted and non-specific drug… read more here.
Keywords: cancer therapeutics; hybrid nanocarrier; lipid polymer; polymer hybrid ... See more keywords